Sarah Chagri

Dr. Sarah Chagri serves as Scientific Coordinator for Graduate Education and Project Leader at the Max Planck Institute for Polymer Research (MPIP), leading the graduate school and representing MPIP in the Max Planck Graduate Center with Johannes Gutenberg University Mainz. Her research is anchored in the Department of Synthesis of Macromolecules under Prof. Tanja Weil.

Education:

• Biomedical Chemistry studies at Johannes Gutenberg University Mainz
• PhD summa cum laude (2024) from MPIP on bioresponsive nanomaterials for controlled intracellular assembly

Her research pioneers bioresponsive polymer nanostructures for intracellular immune modulation, with core expertise in peptide-based systems that self-assemble within cells to disrupt mitochondrial function in tumors. This work bridges synthetic polymer chemistry with translational cancer therapeutics, emphasizing precision nanomaterial design for cellular environments.

Analysis of her publications reveals a cohesive trajectory in nanomedicine: the 2025 Advanced Science paper demonstrates tumor-killing mechanisms via engineered peptide nanostructures, while the 2022 Nature Reviews Chemistry review establishes foundational design principles for intracellular self-assembly. Collectively, these works position her at the forefront of stimuli-responsive biomaterials for oncology applications.

No scientific awards were documented in the source materials.

As Graduate Education Coordinator, Dr. Chagri oversees MPIP's doctoral training program and institutional partnerships, indicating substantial administrative leadership. While specific grant details are unreported, her high-impact publications suggest competitive research funding. She actively mentors graduate students through the MPIP program though individual advisees aren't listed.

Her laboratory work operates within Prof. Weil's research group, leveraging interdisciplinary collaborations across polymer synthesis, nanotechnology, and cancer biology to develop next-generation therapeutic nanostructures with clinical translation potential.